Intervention Group for Renal Disease

Chronic Disease Innovation Centre, Seven Oaks Hospital, Winnipeg, Canada
Renal Disease+1 More ConditionsVIEWER virtual care platform - Device
All Sexes

Study Summary

This trial aims to see if using a virtual care platform can reduce hospital visits and make virtual care safer for patients and providers.

Eligible Conditions
  • End Stage Renal Disease (ESRD)
  • Kidney Failure

Treatment Effectiveness

Study Objectives

1 Primary · 10 Secondary · Reporting Duration: baseline, 3,6,9 and 12 months

12 months
All-cause mortality
Composite of first hospitalization or emergency department (ED) visit
Frequency of Emergency Department Visit
Frequency of formal clinic visits
Patient Perspectives towards intervention (qualitative) focus groups
Proportion of patients greater than 80% adherence
Proportion of patients who have an acute inpatient initiation of dialysis.
Provider Perspectives towards intervention (qualitative) focus groups
System Usability Scale (SUS)
Month 12
UK Kidney PREM score (adapted to CKD)
Month 12
Health related QOL using KQOL-SF

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Control Group
1 of 2
Intervention Group
1 of 2

Active Control

Experimental Treatment

340 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention Group · No Placebo Group · N/A

Intervention Group
Experimental Group · 1 Intervention: VIEWER virtual care platform · Intervention Types: Device
Control GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 3,6,9 and 12 months

Who is running the clinical trial?

University of ManitobaLead Sponsor
557 Previous Clinical Trials
192,860 Total Patients Enrolled
Claudio Rigatto, MDPrincipal InvestigatorUniversity of Manitoba

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there any unfilled vacancies for this trial's participants?

"Affirmative, indicates that this trial is currently seeking subjects to enroll in the study. The listing was initially uploaded on June 30th 2022 and recently updated February 2nd 2023. 340 patients will be recruited from a single site for participation." - Anonymous Online Contributor

Unverified Answer

How many individuals can take part in the experiment?

"Affirmative. An examination of information on reveals that, as of June 30th 2022 and last updated February 2nd 2023, this trial is actively recruiting patients from one facility with a total number of 340 participants sought." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.